Find out more about who we are, what we do and the people behind Epitopea.
Find out what makes us unique and the work we do with our revolutionary CryptoMapTM platform.
All the latest company news, press releases and updates from Epitopea.

About Us

Meet Our Leadership Team

Dr. Alan C. Rigby
CEO
Dr. Jon Moore
Chief Scientific Officer
Dr. Steven Klein
CBO
Dr. Claude Perreault
Co-Founder
Dr. Pierre Thibault
Co-Founder

Clinical and Scientific Advisory Board

Dr. Michael Kalos
Scientific and Clinical Advisory Board Chair

Investors

In 2022, we closed a $14M USD seed round from a transatlantic syndicate of top-tier international life sciences investors.

The company has backing from life science investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital, Le Fonds de Solidarité FTQ, the Harrington Discovery Institute and Novateur Ventures.

Partners

In addition to its top-tier international investor syndicate, Epitopea is also proud to be supported by a strong network of contract partners from the public and private sector, that are providing Epitopea with R&D related support.
Revealing Novel Targets For Next Generation Immunotherapies
© 2022 – 2024 Epitopea Ltd | All Rights Reserved
Created by FDM Digital